New Zyprexa lawsuit targets Lilly honchos: Shareholders ask directors, officers to pay company
The latest shareholder lawsuit against Eli Lilly and Co. over its drug Zyprexa gets personal. The shareholders blame Lilly’s board and top brass, both past and present, for what they call Lilly’s illegal marketing of Zyprexa. In all, the lawsuit asks 18 directors and officers to pay the company for at least the $1.2 billion it has spent to settle Zyprexa lawsuits and to return all compensation they received during an unspecified period when the marketing took place. They name…